NCT05739071Enrolling by invitation
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
JING SI HERBAL TEA in the Treatment of Lower Urinary Tract Symptoms After Intravesical Therapy in Patients With Bladder Cancer
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
To identify the effects of JING SI HERBAL TEA in the treatment of lower urinary tract symptoms after intravesical therapy in patients with bladder cancer.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 13 Jan 2023
- Start date
- 22 Feb 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Diseases
- Bladder cancer
- NCT number
- NCT05739071
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 22 Feb 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Bladder cancer are being treated in another hospital
- Had admitted due to other disease in the past 3 months
Age
- Patients under 20 years old or greater than 100 years old
Other
- Women with pregnancy or breastfeeding plans
- Unable to understand the questionnaire
Who the study is looking for
- Clinical diagnosis bladder cancer
- Under intravesical installation therapy
Age in the registry: 20 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Buddhist Tzu Chi General Hospital, Taipei branch Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.